Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3620141, 5 pages
http://dx.doi.org/10.1155/2016/3620141
Research Article

Comparative Analysis of Human B Cell Epitopes Based on BCG Genomes

State Key Laboratory of Infectious Diseases Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China

Received 22 March 2016; Accepted 16 May 2016

Academic Editor: Frederick D. Quinn

Copyright © 2016 Machao Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. M. Daniel, “The history of tuberculosis,” Respiratory Medicine, vol. 100, no. 11, pp. 1862–1870, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. E. C. Böttger and B. Springer, “Tuberculosis: drug resistance, fitness, and strategies for global control,” European Journal of Pediatrics, vol. 167, no. 2, pp. 141–148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. P. M. Small, R. W. Shafer, P. C. Hopewell et al., “Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection,” The New England Journal of Medicine, vol. 328, no. 16, pp. 1137–1144, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Zhang, F. Huang, W. Chen et al., “Estimates of tuberculosis mortality rates in China using the disease surveillance point system, 2004–2010,” Biomedical and Environmental Sciences, vol. 25, no. 4, pp. 483–488, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. G. A. Colditz, T. F. Brewer, C. S. Berkey et al., “Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature,” The Journal of the American Medical Association, vol. 271, no. 9, pp. 698–702, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. P. E. Fine, “Variation in protection by BCG: implications of and for heterologous immunity,” The Lancet, vol. 346, no. 8986, pp. 1339–1345, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. R. J. North and Y.-J. Jung, “Immunity to tuberculosis,” Annual Review of Immunology, vol. 22, pp. 599–623, 2004. View at Publisher · View at Google Scholar
  8. R. J. North, “Importance of thymus-derived lymphocytes in cell-mediated immunity to infection,” Cellular Immunology, vol. 7, no. 1, pp. 166–176, 1973. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Grange, “The humoral immune response in tuberculosis: its nature, biological role and diagnostic usefulness,” Advances in Tuberculosis Research, vol. 21, pp. 1–78, 1984. View at Google Scholar · View at Scopus
  10. P. J. Maglione, J. Xu, and J. Chan, “B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis,” Journal of Immunology, vol. 178, no. 11, pp. 7222–7234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Lanzavecchia, “Antigen-specific interaction between T and B cells,” Nature, vol. 314, no. 6011, pp. 537–539, 1985. View at Publisher · View at Google Scholar · View at Scopus
  12. P. J. Maglione, J. Xu, A. Casadevall, and J. Chan, “Fcγ receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection,” Journal of Immunology, vol. 180, no. 5, pp. 3329–3338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Behr and P. M. Small, “A historical and molecular phylogeny of BCG strains,” Vaccine, vol. 17, no. 7-8, pp. 915–922, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Liu, V. Tran, A. S. Leung, D. C. Alexander, and B. Zhu, “BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy,” Human Vaccines, vol. 5, no. 2, pp. 70–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Zhang, Y. Zhang, H. Zheng et al., “Genome sequencing and analysis of BCG vaccine strains,” PloS ONE, vol. 8, no. 8, article e71243, 2013. View at Google Scholar · View at Scopus
  16. Y. Pan, X. Yang, J. Duan et al., “Whole-genome sequences of four Mycobacterium bovis BCG vaccine strains,” Journal of Bacteriology, vol. 193, no. 12, pp. 3152–3153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Orduña, M. A. Cevallos, S. P. De León et al., “Genomic and proteomic analyses of Mycobacterium bovis BCG Mexico 1931 reveal a diverse immunogenic repertoire against tuberculosis infection,” BMC Genomics, vol. 12, article 493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Brosch, S. V. Gordon, T. Garnier et al., “Genome plasticity of BCG and impact on vaccine efficacy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 13, pp. 5596–5601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Seki, I. Honda, I. Fujita, I. Yano, S. Yamamoto, and A. Koyama, “Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Guérin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains,” Vaccine, vol. 27, no. 11, pp. 1710–1716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-C. Camus, M. J. Pryor, C. Médigue, and S. T. Cole, “Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv,” Microbiology, vol. 148, no. 10, pp. 2967–2973, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Garnier, K. Eiglmeier, J.-C. Camus et al., “The complete genome sequence of Mycobacterium bovis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7877–7882, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. W. J. Kent, “BLAT—the BLAST-like alignment tool,” Genome Research, vol. 12, no. 4, pp. 656–664, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. S. T. Cole, R. Brosch, J. Parkhill et al., “Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence,” Nature, vol. 393, no. 6685, pp. 537–544, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. P. R. Jungblut, U. E. Schaible, H.-J. Mollenkopf et al., “Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens,” Molecular Microbiology, vol. 33, no. 6, pp. 1103–1117, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. A. S. Pym, P. Brodin, L. Majlessi et al., “Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis,” Nature Medicine, vol. 9, no. 5, pp. 533–539, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Målen, F. S. Berven, K. E. Fladmark, and H. G. Wiker, “Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv,” Proteomics, vol. 7, no. 10, pp. 1702–1718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Gu, J. Chen, K. M. Dobos, E. M. Bradbury, J. T. Belisle, and X. Chen, “Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain,” Molecular & Cellular Proteomics, vol. 9, pp. 117–139, 2000. View at Google Scholar
  28. M. A. Behr, M. A. Wilson, W. P. Gill et al., “Comparative genomics of BCG vaccines by whole-genome DNA microarray,” Science, vol. 284, no. 5419, pp. 1520–1523, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. W. J. Philipp, S. Nair, G. Guglielmi, M. Lagranderie, B. Gicquel, and S. T. Cole, “Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis,” Microbiology, vol. 142, no. 11, pp. 3135–3145, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Parkash, B. P. Singh, and M. Pai, “Regions of differences encoded antigens as targets for immunodiagnosis of tuberculosis in humans,” Scandinavian Journal of Immunology, vol. 70, no. 4, pp. 345–357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. World Health Organization, “BCG vaccine. WHO position paper,” Weekly Epidemiological Record, vol. 79, no. 4, pp. 27–38, 2004. View at Google Scholar
  32. G. A. Colditz, C. S. Berkey, F. Mosteller et al., “The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature,” Pediatrics, vol. 96, no. 1, pp. 29–35, 1995. View at Google Scholar · View at Scopus
  33. B. B. Trunz, P. Fine, and C. Dye, “Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness,” The Lancet, vol. 367, no. 9517, pp. 1173–1180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. Bosio, D. Gardner, and K. L. Elkins, “Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology,” The Journal of Immunology, vol. 164, no. 12, pp. 6417–6425, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Behr and P. M. Small, “Has BCG attenuated to impotence?” Nature, vol. 389, no. 6647, pp. 133–134, 1997. View at Google Scholar · View at Scopus
  36. V. Davids, W. A. Hanekom, N. Mansoor et al., “The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants,” Journal of Infectious Diseases, vol. 193, no. 4, pp. 531–536, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Urwin, J. E. Russell, E. A. L. Thompson, E. C. Holmes, I. M. Feavers, and M. C. J. Maiden, “Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design,” Infection & Immunity, vol. 72, no. 10, pp. 5955–5962, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Kawashima, K. Pfafferott, J. Frater et al., “Adaptation of HIV-1 to human leukocyte antigen class I,” Nature, vol. 458, no. 7238, pp. 641–645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Comas, J. Chakravartti, P. M. Small et al., “Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved,” Nature Genetics, vol. 42, no. 6, pp. 498–503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Dawkins and J. R. Krebs, “Arms races between and within species,” Proceedings of the Royal Society of London—Biological Sciences, vol. 205, no. 1161, pp. 489–511, 1979. View at Publisher · View at Google Scholar · View at Scopus